Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX4 | Q96LA9 | 13/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17356416 | 0.86 | MRGPRX4 (0.52) | MRGPRX4MAPTFFAR1CYP1A2CYP3A4 | |
| SCHEMBL17356510 | 0.83 | CFTR (0.44) | MRGPRX4MAPTGPR35CYP1A2CYP2C9 | |
| SCHEMBL5769694 | 0.83 | KDM4E (0.60) | MRGPRX4FFAR1CYP2C19 | |
| SCHEMBL5277735 | 0.82 | MRGPRX4 (0.51) | MRGPRX4FFAR1 | |
| SCHEMBL17356507 | 0.80 | KDM4E (0.47) | MAPTGPR35CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3712182 | 0.80 | MRGPRX4 (0.53) | MRGPRX4MAPTFFAR1 | |
| SCHEMBL17356479 | 0.80 | GPR35 (0.53) | MAPTGPR35CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL17355797 | 0.78 | MRGPRX4 (0.43) | MRGPRX4MAPTCYP2C9CYP2C19 | |
| SCHEMBL1688243 | 0.77 | MAPT (0.50) | MRGPRX4MAPTFFAR1CYP1A2CYP3A4 | |
| SCHEMBL3860646 | 0.76 | FFAR1 (0.49) | MRGPRX4FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150372349-A1 | NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE | UBE INDUSTRIES, LTD. (JP) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150372349-A1 | NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE | HCN2, SCO2, HCN1 | MRGPRX4 4355/4885MAPT 4452/4885FFAR1 724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.